Healthcare - Biotechnology - NASDAQ - US
$ 235.56
-8.67 %
$ 30.4 B
Market Cap
-92.38
P/E
Price Target
Average
26.36%
Revenue Forecast
Estimate
33.17%
EBIT
Estimate
--100.27%
Net Income
Estimate
53.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alnylam Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ALNY of $298 , with forecasts ranging from a low of $234 to a high of $400 .
ALNY Lowest Price Target
Wall Street Target
234 USD
-0.66%
ALNY Average Price Target
Wall Street Target
298 USD
26.36%
ALNY Highest Price Target
Wall Street Target
400 USD
69.81%
REVENUE FORECAST
Revenue Forecast Chart ALNY
EBIT FORECAST
EBIT Forecast Chart ALNY
NET INCOME FORECAST
Net Income Chart ALNY